141 related articles for article (PubMed ID: 2526844)
21. Regulation of oxytocin, oestradiol and progesterone receptor concentrations in different uterine regions by oestradiol, progesterone and oxytocin in ovariectomized ewes.
Wathes DC; Mann GE; Payne JH; Riley PR; Stevenson KR; Lamming GE
J Endocrinol; 1996 Dec; 151(3):375-93. PubMed ID: 8994383
[TBL] [Abstract][Full Text] [Related]
22. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
Lumsden MA; West CP; Thomas E; Coutts J; Hillier H; Thomas N; Baird DT
Br J Obstet Gynaecol; 1994 May; 101(5):438-42. PubMed ID: 8018618
[TBL] [Abstract][Full Text] [Related]
23. Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women.
Matta WH; Shaw RW; Burford GD
Fertil Steril; 1988 Jan; 49(1):163-5. PubMed ID: 2961621
[TBL] [Abstract][Full Text] [Related]
24. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
[TBL] [Abstract][Full Text] [Related]
25. [Interaction of tamoxifen with cytosol estradiol receptors in myoma and histologically unchanged myometrium].
Kareva EN; Kostyleva OI
Biull Eksp Biol Med; 1993 Mar; 115(3):264-5. PubMed ID: 8054615
[TBL] [Abstract][Full Text] [Related]
26. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
27. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Kaufmann M; Jonat W; Kleeberg U; Eiermann W; Jänicke F; Hilfrich J; Kreienberg R; Albrecht M; Weitzel HK; Schmid H
J Clin Oncol; 1989 Aug; 7(8):1113-9. PubMed ID: 2526863
[TBL] [Abstract][Full Text] [Related]
28. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
Cheng YM; Chou CY; Huang SC; Lin HC
BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
[TBL] [Abstract][Full Text] [Related]
29. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.
Wu X; Wang H; Englund K; Blanck A; Lindblom B; Sahlin L
Fertil Steril; 2002 Nov; 78(5):985-93. PubMed ID: 12413982
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
32. [The estimation of LHRH receptors in the tissue of human leiomyoma, myometrium and endometrium].
Marinaccio M; Reshkin S; Pinto V; Paradiso A
Minerva Ginecol; 1994 Oct; 46(10):519-26. PubMed ID: 7838406
[TBL] [Abstract][Full Text] [Related]
33. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
Costantini S; Anserini P; Valenzano M; Remorgida V; Venturini PL; De Cecco L
Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):63-9. PubMed ID: 2142921
[TBL] [Abstract][Full Text] [Related]
34. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
35. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
Rein MS; Friedman AJ; Heffner LJ
J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
[TBL] [Abstract][Full Text] [Related]
36. Effects of gonadotrophin-releasing hormone agonist on uterine fibroids and bone density.
Bianchi G; Costantini S; Anserini P; Rovetta G; Monteforte P; Menada MV; Fagà L; De Cecco L
Maturitas; 1989 Sep; 11(3):179-85. PubMed ID: 2512467
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue.
Pollow K; Geilfuss J; Boquoi E; Pollow B
J Clin Chem Clin Biochem; 1978 Sep; 16(9):503-11. PubMed ID: 712341
[TBL] [Abstract][Full Text] [Related]
38. The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month.
Hackenberg R; Gesenhues T; Deichert U; Duda V; Schmidt-Rhode P; Schulz KD
Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(2):125-9. PubMed ID: 1386817
[TBL] [Abstract][Full Text] [Related]
39. Two types of nuclear oestradiol binding sites in human myometrium and leiomyoma during the menstrual cycle.
Környei J; Csermely T; Székely JA; Vértes M
Exp Clin Endocrinol; 1986 Aug; 87(3):256-64. PubMed ID: 3780865
[TBL] [Abstract][Full Text] [Related]
40. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
